Isofol Medical: Further additions to the patent portfolio
Research Note
2019-06-25
17:23
Isofol reports that the company has received another clinical use patent for arfolitixorin in the US. Today’s news does not affect our valuation of the company.
AN
Arvid Necander
Disclosures and disclaimers